http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-101701227-B1
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K35-50 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-20 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-16 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-48 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P19-08 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-48 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-16 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-20 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K35-50 |
| filingDate | 2015-02-12-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2017-02-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2017-02-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | KR-101701227-B1 |
| titleOfInvention | Pharmaceutical composition for promoting bone formation comprising the complex extract of amniotic membrane and chorion membrane |
| abstract | The present invention relates to a pharmaceutical composition for accelerating osteogenesis, which comprises a complex extract of amniotic membrane and chorionic membrane as an active ingredient. The pharmaceutical composition according to the present invention promotes osteogenesis by promoting expression of an osteogenesis promoting gene and promotes osteogenesis such as osteoporosis, osteoporosis, osteoporotic fracture, diabetic fracture, nonunion fracture, osteogenic insufficiency, Fracture due to osteoporosis, osteoarthritis, degenerative bone disease or malocclusion and bone formation or bone regeneration. |
| isCitedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-20220150024-A |
| priorityDate | 2015-02-12-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 188.